ZNF317 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.172300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.658200E-02
Normal-vs-Stage2
5.060400E-02
Normal-vs-Stage3
3.866100E-02
Normal-vs-Stage4
3.946600E-01
Stage1-vs-Stage2
8.322800E-01
Stage1-vs-Stage3
3.505800E-02
Stage1-vs-Stage4
3.561800E-01
Stage2-vs-Stage3
1.067600E-01
Stage2-vs-Stage4
3.589400E-01
Stage3-vs-Stage4
4.598000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.374500E-02
Normal-vs-AfricanAmerican
2.537400E-01
Normal-vs-Asian
3.513600E-02
Caucasian-vs-AfricanAmerican
9.535600E-01
Caucasian-vs-Asian
4.535600E-01
AfricanAmerican-vs-Asian
6.194600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.768500E-02
Normal-vs-Female
8.307800E-02
Male-vs-Female
5.225400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.888600E-01
Normal-vs-Age(41-60Yrs)
9.638300E-02
Normal-vs-Age(61-80Yrs)
4.808100E-02
Normal-vs-Age(81-100Yrs)
2.584100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.970400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.227400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.922600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.587800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.404200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.115800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.172180E-02
Normal-vs-Daily Drinker
2.068300E-02
Normal-vs-Weekly Drinker
1.472040E-01
Normal-vs-Occasional Drinker
4.761600E-02
Normal-vs-Social Drinker
2.391400E-01
Non Drinker-vs-Daily Drinker
9.861400E-01
Non Drinker-vs-Weekly Drinker
1.813980E-01
Non Drinker-vs-Occasional Drinker
5.992000E-02
Non Drinker-vs-Social Drinker
3.686100E-02
Daily Drinker-vs-Weekly Drinker
2.218000E-01
Daily Drinker-vs-Occasional Drinker
8.233500E-02
Daily Drinker-vs-Social Drinker
5.737500E-02
Weekly Drinker-vs-Occasional Drinker
8.634800E-01
Weekly Drinker-vs-Social Drinker
5.683000E-01
Occasional Drinker-vs-Social Drinker
5.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.660600E-01
Normal-vs-Grade 2
6.079800E-01
Normal-vs-Grade 3
1.408220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.973000E-01
Grade 1-vs-Grade 3
8.402000E-01
Grade 1-vs-Grade 4
2.660600E-01
Grade 2-vs-Grade 3
9.460400E-01
Grade 2-vs-Grade 4
6.079800E-01
Grade 3-vs-Grade 4
1.408220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.153170E-01
Normal-vs-NonDiabetic
3.318200E-02
Diabetic-vs-NonDiabetic
8.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.073500E-02
Normal-vs-NoPancreatitis
5.977600E-02
Pancreatitis-vs-NoPancreatitis
3.272800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.644100E-02
Normal-vs-N1
6.957700E-02
N0-vs-N1
4.729800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.294380E-01
Normal-vs-TP53-NonMutant
2.328600E-01
TP53-Mutant-vs-TP53-NonMutant
4.823800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
